Paul Mahon files Form 144 to sell 8,300 shares

Paul Mahon submitted a Form 144 proposing to sell 8,300 common shares via a stock options exercise with an intended transaction date of 02/19/2026.

Rhea-AI Filing Summary

Paul Mahon submitted a Form 144 proposing to sell 8,300 common shares via a stock options exercise with an intended transaction date of 02/19/2026. The filing also lists multiple recent dispositions by the same person, including sales of 8,300 shares on 02/05/2026 and 8,300 shares on 01/15/2026.

Insights

Securities Compliance Counsel

Routine Form 144 notice of proposed insider sale; transaction tied to option exercise.

The filing shows a proposed sale of 8,300 common shares by Paul Mahon through a stock options exercise scheduled for 02/19/2026. Form 144 is a notification required when officers/directors/affiliates plan to sell restricted or control securities.

Regulatory implications are procedural: the notice itself does not complete a sale. Subsequent filings or broker reports would reflect whether the sale occurred and at what price; timing and cash‑flow treatment are tied to the stated exercise and sale method.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Paul Mahon's Form 144 for UTHR disclose?

It discloses a proposed sale of 8,300 common shares via a stock options exercise with an intended date of 02/19/2026. The filing lists prior dispositions in recent months by the same individual.

Does the Form 144 mean the sale has completed for UTHR?

No, Form 144 is a notice of a proposed sale rather than proof of completion. Completion and sale price would appear in subsequent broker reports or a later Form 4 if required.

How many recent sales by Paul Mahon are shown in the filing?

The filing lists multiple recent dispositions, including sales of 8,300 shares on 02/05/2026 and 8,300 shares on 01/15/2026, among other dates and amounts in late 2025 and early 2026.

What method is listed for the proposed UTHR sale on 02/19/2026?

The method is described as a stock options exercise with the issuer named in the transaction and cash indicated as the consideration, per the filing entry for 02/19/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001231589
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNITED THERAPEUTICS CORPORATION
SEC File Number	000-26301
Address of Issuer	1000 SPRING STREET SILVER SPRING MARYLAND 20910
Phone	(301) 608-9292
Name of Person for Whose Account the Securities are To Be Sold	PAUL MAHON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8300	3953587.97	43056599	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2026	Stock Options Exercise	Issuer			8300	02/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	02/05/2026	8300	4010939.31
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	01/15/2026	8300	3900121.86
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	01/02/2026	8300	4029076.47
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	12/24/2025	11000	5644953.60
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	12/11/2025	11000	5331316.10
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	11/26/2025	11000	5346700.70

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Paul A. Mahon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)